Women In High Places: Slow Progress In Pharma

Female Executives Share Their Views

With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.

Blue_Red_Figures

More from Leadership

More from Scrip